In May 2010, the European debt crisis forced the European Commission to abandon its earlier "no bail out" policy and establish a massive safety net for the European periphery. But by the end of November, 2010, markets demanded record high interest rates on the European periphery's sovereign debt.

At this event, Legatum Institute senior vice president William Inboden and senior fellow Ryan Streeter will present the findings of the 2009 Prosperity Index.

American Enterprise Institute (AEI) economist  Roger Bate shares his expertise on counterfeit drug networks that pose a growing threat to combating diseases like malaria.

The Kimberly Process has become a whitewash; Roger Bate reports from Africa.

Online registration for this event is closed. Walk-in registrations will be accepted.

What does it mean to prosper? Is prosperity just the accumulation of material wealth, or are there other determinants to overall well-being? Why is there a great divide in life satisfaction between Denmark and Hong Kong despite their...

In a just-published op-ed in the New York Times, American Enterprise Institute (AEI) international health economist Roger Bate highlights a better way to fight fake pharmaceuticals while still giving poor Americans access to less costly drugs from online pharmacies.

Evidence from numerous studies shows that emerging markets have far more poor quality drugs than western markets. There are many reasons for this, but one reason, investigated in this paper, is the possibility that smaller, often privately-owned, pharmacies take greater risks with drug procurement than larger organizations, which are often franchises or major pharmacy chains.